Literature DB >> 28608224

Concordance between the old and new diagnostic criteria for periprosthetic joint infection.

Meeri Honkanen1,2, Esa Jämsen3,4, Matti Karppelin5, Reetta Huttunen5, Outi Lyytikäinen6, Jaana Syrjänen5,3.   

Abstract

PURPOSE: There is no uniform definition for periprosthetic joint infection (PJI). New diagnostic criteria were formulated in an international consensus meeting in 2013 and adopted by Centers for Disease Control (CDC) in 2016. The purpose of this study is to compare the new diagnostic criteria with the old CDC criteria from the year 1992.
METHODS: Patients, who had been treated for PJI of hip or knee from 2002 to 2014, in a tertiary care hospital, were identified. Patient records were reviewed by a physician to identify PJI cases fulfilling the old or new CDC criteria and to record data concerning the diagnostic criteria. PJI frequencies were calculated for the two diagnostic criteria sets. Cross tables were formed to compare the concordance between the two sets of criteria in the whole material and in different clinical subgroups.
RESULTS: Overall 405 cases fulfilling either or both sets of criteria for PJI were identified. 73 (18%) of the patients fulfilled only the old criteria, whereas only one (0.2%) fulfilled only the new criteria. Of the patients who did not fulfil the new criteria, in 39 (53%) the diagnosis was based solely on the clinician's opinion.
CONCLUSIONS: The number of PJIs is notably lower when using the new, more objective, diagnostic criteria. A large portion of the cases diagnosed as infection by the treating clinician, did not fulfil the new diagnostic criteria.

Entities:  

Keywords:  Diagnosis; Healthcare-associated infections; Prosthetic joint infection; Surveillance

Mesh:

Year:  2017        PMID: 28608224     DOI: 10.1007/s15010-017-1038-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Validation of surgical site infection surveillance in orthopedic procedures.

Authors:  Kaisa Huotari; Niina Agthe; Outi Lyytikäinen
Journal:  Am J Infect Control       Date:  2007-05       Impact factor: 2.918

2.  Diagnosis of periprosthetic joint infection.

Authors:  Benjamin Zmistowski; Craig Della Valle; Thomas W Bauer; Konstantinos N Malizos; Abbas Alavi; Hani Bedair; Robert E Booth; Peter Choong; Carl Deirmengian; Garth D Ehrlich; Anil Gambir; Ronald Huang; Yair Kissin; Hideo Kobayashi; Naomi Kobayashi; Veit Krenn; Drago Lorenzo; S B Marston; Geert Meermans; Javier Perez; J J Ploegmakers; Aaron Rosenberg; Peter Thomas; Stephan Tohtz; Jorge A Villafuerte; Peter Wahl; Frank-Christiaan Wagenaar; Eivind Witzo
Journal:  J Orthop Res       Date:  2014-01       Impact factor: 3.494

Review 3.  Diagnosis of Periprosthetic Joint Infection Following Hip and Knee Arthroplasty.

Authors:  Javad Parvizi; Safa Cyrus Fassihi; Mohammad A Enayatollahi
Journal:  Orthop Clin North Am       Date:  2016-04-22       Impact factor: 2.472

4.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori; V P Munn; T M Hooton
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

5.  Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group.

Authors:  B L Atkins; N Athanasou; J J Deeks; D W Crook; H Simpson; T E Peto; P McLardy-Smith; A R Berendt
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 6.  Periprosthetic joint infection.

Authors:  Bhaveen H Kapadia; Richard A Berg; Jacqueline A Daley; Jan Fritz; Anil Bhave; Michael A Mont
Journal:  Lancet       Date:  2015-06-28       Impact factor: 79.321

7.  Failure of metal-on-metal total hip arthroplasty mimicking hip infection. A report of two cases.

Authors:  Mark M Mikhael; Arlen D Hanssen; Rafael J Sierra
Journal:  J Bone Joint Surg Am       Date:  2009-02       Impact factor: 5.284

8.  Culture-negative prosthetic joint infection.

Authors:  Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon
Journal:  Clin Infect Dis       Date:  2007-09-26       Impact factor: 9.079

9.  Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection.

Authors:  Andrej Trampuz; Arlen D Hanssen; Douglas R Osmon; Jayawant Mandrekar; James M Steckelberg; Robin Patel
Journal:  Am J Med       Date:  2004-10-15       Impact factor: 4.965

10.  Reduction in wound infection rates by wound surveillance with postdischarge follow-up and feedback.

Authors:  A P R Wilson; B Hodgson; M Liu; D Plummer; I Taylor; J Roberts; M Jit; C Sherlaw-Johnson
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

View more
  4 in total

1.  DOES TOPICAL USE OF GENTAMICIN REDUCE THE INFECTION RATE IN PRIMARY TOTAL HIP ARTHROPLASTY?

Authors:  Caio Luiz de Toledo Oliveira; Felipe Abrahão Elias; André Dos Santos Ribacionka; Celso Hermínio Ferraz Picado; Flávio Luís Garcia
Journal:  Acta Ortop Bras       Date:  2019 Jul-Aug       Impact factor: 0.513

2.  Periprosthetic Joint Infections as a Consequence of Bacteremia.

Authors:  Meeri Honkanen; Esa Jämsen; Matti Karppelin; Reetta Huttunen; Antti Eskelinen; Jaana Syrjänen
Journal:  Open Forum Infect Dis       Date:  2019-05-07       Impact factor: 3.835

3.  Significance of nutritional status in the development of periprosthetic infections : A retrospective analysis of 194 patients.

Authors:  Dirk Zajonz; Alexandros Daikos; Florian Prager; Melanie Edel; Robert Möbius; Johannes K M Fakler; Andreas Roth; Mohamed Ghanem
Journal:  Orthopade       Date:  2021-03       Impact factor: 1.087

4.  Effectiveness and Prognosis: Drainage Skin-Bridge Sparing Surgery Combined with Fistulotomy versus Fistulotomy Only in the Treatment of Anal Fistula.

Authors:  Xiao Wang; Chunliang Wang; Ruihua Qi
Journal:  J Healthc Eng       Date:  2021-11-28       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.